Invention Grant
- Patent Title: Substituted 6,5-fused bicyclic heteroaryl compounds
-
Application No.: US15162384Application Date: 2016-05-23
-
Publication No.: US10174019B2Publication Date: 2019-01-08
- Inventor: John Emmerson Campbell , Kevin Wayne Kuntz
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Xixi Sun
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D401/14 ; A61K31/437 ; C07D401/10 ; A61K31/4353 ; C07D471/04 ; C07D231/56 ; C07D403/12 ; C07D413/12 ; C07D417/12 ; C07D519/00
Abstract:
The present invention relates to azole bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
Public/Granted literature
- US20160326170A1 SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Public/Granted day:2016-11-10
Information query
